218 related articles for article (PubMed ID: 33389224)
1. Promising Antifungal Potential of Engineered Non-ionic Surfactant-Based Vesicles: In Vitro and In Vivo Studies.
Verma A; Jain A; Tiwari A; Saraf S; Panda PK; Jain SK
AAPS PharmSciTech; 2021 Jan; 22(1):19. PubMed ID: 33389224
[TBL] [Abstract][Full Text] [Related]
2. Systematic optimization of cationic surface engineered mucoadhesive vesicles employing Design of Experiment (DoE): A preclinical investigation.
Verma A; Sharma G; Jain A; Tiwari A; Saraf S; Panda PK; Katare OP; Jain SK
Int J Biol Macromol; 2019 Jul; 133():1142-1155. PubMed ID: 31004631
[TBL] [Abstract][Full Text] [Related]
3. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
5. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
6. Niosomes: Do They Increase the Potency of Topical Natamycin Ketorolac Formula in Treating Aspergillus Keratitis? An Experimental Study.
El-Mofty HM; El-Nabarawi MA; Abd El Rehem RT; Teaima MH; Abary MYS; Salah M; Lotfy NM
J Ocul Pharmacol Ther; 2020 Sep; 36(7):545-554. PubMed ID: 32357092
[No Abstract] [Full Text] [Related]
7. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
[TBL] [Abstract][Full Text] [Related]
8. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
[TBL] [Abstract][Full Text] [Related]
9. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
Shaikh KS; Chellampillai B; Pawar AP
Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
11. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
[TBL] [Abstract][Full Text] [Related]
12. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.
El-Ridy MS; Abdelbary A; Essam T; El-Salam RM; Kassem AA
Drug Dev Ind Pharm; 2011 Dec; 37(12):1491-508. PubMed ID: 21707323
[TBL] [Abstract][Full Text] [Related]
13. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
[TBL] [Abstract][Full Text] [Related]
14. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
15. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein.
Khan MI; Madni A; Peltonen L
Eur J Pharm Sci; 2016 Dec; 95():88-95. PubMed ID: 27600819
[TBL] [Abstract][Full Text] [Related]
16. Cationic niosomes composed of spermine-based cationic lipids mediate high gene transfection efficiency.
Paecharoenchai O; Niyomtham N; Ngawhirunpat T; Rojanarata T; Yingyongnarongkul BE; Opanasopit P
J Drug Target; 2012 Nov; 20(9):783-92. PubMed ID: 22931523
[TBL] [Abstract][Full Text] [Related]
17. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
[TBL] [Abstract][Full Text] [Related]
18. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Abdelbary AA; AbouGhaly MH
Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
[TBL] [Abstract][Full Text] [Related]
19. Optimized mucoadhesive niosomal carriers for intranasal delivery of carvedilol: A quality by design approach.
Azrak ZAT; Taha MS; Jagal J; Elsherbeny A; Bayraktutan H; AbouGhaly MHH; Elshafeey AH; Greish K; Haider M
Int J Pharm; 2024 Apr; 654():123935. PubMed ID: 38395319
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
